Susquehanna International Group’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Sell
136,284
-14,272
-9% -$180K ﹤0.01% 7336
2025
Q4
$2.06M Buy
+150,556
New +$2.79M ﹤0.01% 5601
2025
Q3
Sell
-75,607
Closed -$891K 12560
2025
Q2
$903K Sell
75,607
-406,765
-84% -$5.12M ﹤0.01% 7701
2025
Q1
$5.74M Sell
482,372
-26,792
-5% -$417K ﹤0.01% 3394
2024
Q4
$7.83M Buy
509,164
+358,189
+237% +$4.64M ﹤0.01% 2957
2024
Q3
$1.69M Buy
150,975
+76,408
+102% +$732K ﹤0.01% 5621
2024
Q2
$402K Buy
74,567
+49,634
+199% +$287K ﹤0.01% 8784
2024
Q1
$170K Buy
24,933
+7,270
+41% +$50.8K ﹤0.01% 10781
2023
Q4
$120K Buy
+17,663
New +$100K ﹤0.01% 11179
2023
Q3
Sell
-23,425
Closed -$139K 12104
2023
Q2
$170K Sell
23,425
-124,222
-84% -$1.06M ﹤0.01% 10449
2023
Q1
$1.25M Buy
147,647
+19,075
+15% +$167K ﹤0.01% 6250
2022
Q4
$1.09M Buy
128,572
+103,974
+423% +$985K ﹤0.01% 5997
2022
Q3
$255K Buy
+24,598
New +$324K ﹤0.01% 10220
2022
Q2
Sell
-22,152
Closed -$226K 12988
2022
Q1
$231K Sell
22,152
-40,783
-65% -$371K ﹤0.01% 10890
2021
Q4
$706K Sell
62,935
-12,235
-16% -$183K ﹤0.01% 8232
2021
Q3
$1.33M Sell
75,170
-42,012
-36% -$788K ﹤0.01% 6800
2021
Q2
$2.24M Buy
117,182
+27,427
+31% +$530K ﹤0.01% 5662
2021
Q1
$1.9M Buy
+89,755
New +$1.92M ﹤0.01% 6053

Other funds holding CLPT

Susquehanna International Group's CLPT Position: Q1 2026 in Review

Susquehanna International Group reduced its ClearPoint Neuro (CLPT) stake by 9.5% in Q1 2026, selling an estimated $180K and leaving 136,284 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #7336.

Susquehanna International Group first reported a position in CLPT in Q1 2021 and has held it in 18 quarters since. The position peaked at $7.83M in Q4 2024. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Susquehanna International Group held 136,284 shares of ClearPoint Neuro worth $1.24M as of Q1 2026.
  • Susquehanna International Group sold 14,272 ClearPoint Neuro shares in Q1 2026, an estimated $180K.
  • ClearPoint Neuro made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7336 holding.
  • Susquehanna International Group first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 18 quarters since.
  • Susquehanna International Group's ClearPoint Neuro position peaked at $7.83M in Q4 2024.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.